pharmaceutical industry

Roche Invests $50 Billion in Pharmaceuticals & Diagnostics

Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.

HAS Acquires Cerbios-Pharma

HAS Healthcare Advanced Synthesis (HAS) recently announced the planned acquisition of Cerbios-Pharma (Cerbios), a globally recognized manufacturer of chemical and biological APIs, including antibody-drug conjugates (ADCs).

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.

The Future of the Pharmaceutical World

Major and local pharma companies, CMOs, CDMOs, service and equipment providers gather at the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) to discuss new technologies and ongoing trends, as well as to establish business connections. The Congress takes place in Berlin, Germany, on April, 14-15, 2025.

Pharma’s Digital Transformation

Industry experts Michelangelo Canzoneri, Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 guide core team – explain the transformational challenges and critical success factors of the digital Pharma 4.0 journey.

Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer.

Siegfried to Acquire Early-Phase CDMO in US

Siegfried, a global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen, Switzerland, has signed binding agreements with Curia Global for the acquisition of an early-phase CDMO site in Grafton, Wisconsin, US.

Kühne Holding Acquires Aenova from BC Partners

Kühne Holding has agreed to purchase Aenova Group, a pharma contract development and manufacturing organization (CDMO), from BC Partners. BC will reinvest and retain a minority stake in Aenova. The financial terms remain undisclosed.

Integrated Continuous Manufacturing in Pharmaceuticals

An innovative manufacturing platform called integrated continuous manufacturing (ICM) represents a completely modernized model for drug manufacturing. In contrast to batch processes, ICM’s unique operational advantages will allow for cost-competitive end-to-end manufacturing and enable a more robust and responsive supply chain for critical drugs.

SGD Pharma Boosts Siliconized Glass Vial Capacity with New Line in France

SGD Pharma announced the opening of a new siliconization operation at its Saint-Quentin Lamotte (SQLM) plant. The company enhances its range of in-house services by internalizing its glass siliconization offer, ensuring increased responsiveness, security of supply and improved flexibility of vial sizes.

Isomorphic Labs to Collaborate with Eli Lilly and Novartis

Isomorphic Labs announced strategic collaborations with leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be worth nearly €2.75 billion ($3 billion) to Isomorphic Labs, excluding any royalties that may result from future drug sales. Both collaborations are multi-target, focused on small molecules, and include a combination of upfront and milestone payments.

Gilead and Compugen Strike Exclusive Deal for New Immunotherapy Program

Gilead has exclusive rights for the advancement and commercialization of anti-IL18 binding protein antibodies targeting various tumor types. Gilead commits to a significant deal, including a €55 million ($60 million) upfront payment and a €27 million ($30 million) milestone payment in the near term, with a total potential value of up to €775 million ($848 million).

Merck & Co. to Acquire Caraway Therapeutics

Merck & Co. (MSD) and Caraway Therapeutics announced that the companies have agreed Merck & Co., through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to €557 million ($610 million), including an undisclosed upfront payment and contingent milestone payments.

Quotient Sciences Bolsters Sterile Fill/Finish Capacity

Quotient Sciences, a drug development and manufacturing accelerator, has invested significantly in expanding its sterile fill/finish capabilities at its Alnwick, UK facility. This expansion aims to meet the rising demand in the industry for comprehensive drug development programs by enhancing the capacity of the Annex 1-compliant facility.

CPHI Annual Report on Pharmaceutical Industry

The 7th edition of the CPHI Annual Survey was unveiled today highlighting trends for 2024. A total of 250 pharmaceutical executives were surveyed with 35 probing questions, with their answers informing the industry landscape for the next year, spanning all major pharma markets.

European Drugmakers Slam EU Reform Proposals

European NGOs have welcomed the EU’s plans for an overhaul of pharmaceutical legislation – the first in two decades – presented this week in Brussels. The drugs industry, however, has expressed sharp criticism.

Global Pharma Reduces Marketing Staff in India

As part of what seems to be a general pattern of staff reductions in the pharmaceutical industry worldwide, a growing number of Western drugmakers are downsizing their sales and marketing presence in India.

Bachem Inks $531 Million Peptides Manufacturing Deal

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has signed another order worth more than 500 million Swiss francs – or $531 million – to supply large volumes of peptides following a joint development project. The identity of the customer has not been disclosed.

US FTC Wants Court to Hold “Pharma Bro” in Contempt

The Federal Trade Commission (FTC) has asked a US federal judge to hold “pharma bro” Martin Shkreli in contempt for forming another drug company that it said violates a January 2022 court order that banned him from working in the pharmaceutical industry

Flow Chemistry

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

GSK Names Julie Brown as first female CFO

From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced the appointment of Julie Brown, the first woman to be its chief financial officer.

Solving the Riddle of Supply Chain Visibility

Supply chain visibility (SCV) seems to be on everyone’s agenda right now. However, when talking to companies, it quickly becomes clear that everyone has a different picture of visibility. Basically, visibility is about knowing more than you knew before, and this is what most companies still agree on.

How to Make Supply Chains Resilient

When the pandemic was pounding at their doors, many industries were rattled. Healthcare and chemicals were adapting rather successfully to the new normal, as a McKinsey & Company survey reveals.

Novotech Boosts US Presence with NCGS Buy

Asia-Pacific contract research organization (CRO) Novotech has acquired NCGS, a US CRO with about 300 employees and a biopharma client base. Financial terms of the transaction were not disclosed. “This is a strategic move to provide US-based expertise and infrastructure for our US clients wanting trials in Asia-Pacific and the US, and for our Asia-Pacific clients wanting US clinical program, said Novotech CEO John Moller.

Shaping the Future of the Pharma Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2022 Facility of the Year Awards (FOYA) Category Winners – including an Honorable Mention for Iovance Biotherapeutics, to be the first company in the world to commercially produce a personalized therapy for solid tumors.

Solvent Abatement and VOC Recovery for Pharmaceutical Manufacturers

Learn about the merits of cryo condensation and its unique sustainability for the pharmaceutical industry.

The Transition to Digitalization in the Pharmaceutical Industry

ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating model that is interconnected, meaning that the digital tools allow for a fully connected network to enable direct communication between all levels in an organization.

A Roadmap for Pharma 4.0

Industry experts Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 group – talk about the idea behind ISPE’s Pharma 4.0 initiative and the challenges on the way to realize the digital transformation of the pharmaceutical industry.

Innovation and Creativity in the Pharmaceutical Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special Recognition Awards for Operational Agility: Covid-19 Impact.

High Quality and Flexibility for Pharmaceutical Customers

WeylChem’s Custom Manufacturing division has a strong record of accomplishments operating in markets such as Pharma, Agro and Pigments.

Pharmaceutical Logistics in North America

The Risk of Dependency in Pharma Supply Chains

Chemical Process Research and Development

Continuous Pharmaceutical Manufacturing

Economic Impact and Challenges of Continuous Pharma Processes